Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ https://t.co/SYMmzXZ9BU
— The Propell Group (@ThePropellGroup) November 7, 2018
Goldman Sachs asks in biotech research report: ‘Is curing patients a sustainable business model?’ https://t.co/SYMmzXZ9BU
— The Propell Group (@ThePropellGroup) November 7, 2018